Gemabank (IMCB, MOEX: GEMA) shareholders, at their annual General Meeting (AGM), resolved to pay dividends of 2 rubles 40 kopecks per ordinary share. The record date is June 16, 2025.
At the annual General Meeting, shareholders also approved the 2024 annual report, which is available at the company's website for investors.
IMCB is part of Artgen Biotech Group (MOEX: ABIO). Gemabank is a biotechnology company specializing in personal stem cell banking and the development of gene therapy drugs for treating blood and immune system diseases.